Omnicell anticipates 2025 total revenue to range from $1.105 million to $1.155 million, with product bookings expected between $500 million and $550 million and annual recurring revenue ( ARR) ...
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q4 CY2024 results topping the market’s revenue expectations, with ...
Benchmark analysts maintained a Buy rating on Omnicell stock (NASDAQ:OMCL) with a consistent price target of $62.00 as the company approaches its earnings release scheduled for February 6. The target ...
The Pittsburgh region has seen more than its share of commercialized safety innovations that have been born and bred in our ...
Industry players like Omnicell and Allscripts are raking in millions from the sale of software and related hardware, professional services and IT outsourcing services, and recurring service ...
Zacks Medical Info Systems industry stocks like Enovis, Omnicell and Phreesia are expected to gain from the GenAI wave.
A host of hospital building projects in England are being delayed with some having to wait up to 14 years before work starts, the government says. Health Secretary Wes Streeting said the plans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results